EMMA: Empowerment, Motivation and Medical Adherence
EMMA
1 other identifier
interventional
270
1 country
1
Brief Summary
EMMA: Empowerment, Motivation and Medical Adherence. A consultation program based on dialogue tools for adults with poorly regulated Type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus-type-2
Started Nov 2014
Longer than P75 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 5, 2014
CompletedFirst Posted
Study publicly available on registry
November 20, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedNovember 21, 2014
November 1, 2014
2.8 years
November 5, 2014
November 20, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HbA1c
Change from baseline in HbA1c at 4½ month which is maintained or improved at 6 months
Baseline, 4½ month and 6 months after end of intervention period
Secondary Outcomes (5)
Self-management
Baseline, 4½ month and 6 months after end of intervention period
Self-management
Baseline, 4½ month and 6 months after end of intervention period
Self-management
Baseline, 4½ month and 6 months after end of intervention period
Self-management
Baseline, 4½ month and 6 months after end of intervention period
Self-management
Baseline, 4½ month and 6 months after end of intervention period
Study Arms (2)
Intervention group
EXPERIMENTALIntervention arm : EMMA consultations
Control group
NO INTERVENTIONControl arm: Usual care/consultations
Interventions
Eligibility Criteria
You may qualify if:
- Adults Type 2 diabetes ≥ 18 år
- Type 2 diabetes ≥ 1 år
- HbA1c ≥ 64 mmol/mol (≥ 8%) at the last three measures before randomisation
- Taking medication for Type 2 diabetes • - Speak, read and understands Danish
You may not qualify if:
- Participating in other intervention research projects during the trial period
- Being treated by a psychiatrist or psychologist during the period
- Reduced sight or blindness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gitte R Husted
Gentofte Municipality, 2820, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gitte R Husted, PhD
Steno Diabetes Center, Denmark
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher PhD
Study Record Dates
First Submitted
November 5, 2014
First Posted
November 20, 2014
Study Start
November 1, 2014
Primary Completion
August 1, 2017
Study Completion
November 1, 2017
Last Updated
November 21, 2014
Record last verified: 2014-11